Vanda Pharmaceuticals Inc’s filing revealed that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $25863.0 on Nov 14 ’24. In the deal valued at $5.17 per share,5,000 shares were sold. As a result of this transaction, Mitchell Stephen Ray now holds 44,857 shares worth roughly $0.22 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mitchell Stephen Ray bought 5,000 shares, generating $27,000 in total proceeds.
Before that, Moran Kevin Patrick sold 2,251 shares. Vanda Pharmaceuticals Inc shares valued at $13,327 were divested by the SVP, CFO & Treasurer at a price of $5.92 per share. As a result of the transaction, Moran Kevin Patrick now holds 228,763 shares, worth roughly $1.12 million.
H.C. Wainwright initiated its Vanda Pharmaceuticals Inc [VNDA] rating to a Buy in a research note published on October 31, 2024; the price target was $18. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid July with a ‘”an Overweight”‘ rating. Jefferies also remained covering VNDA and has decreased its forecast on February 25, 2022 with a “Hold” recommendation from previously “Buy” rating. BofA Securities started covering the stock on May 12, 2021. It rated VNDA as “a Buy”.
Price Performance Review of VNDA
On Tuesday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock fall -2.58% to $4.91. Over the last five days, the stock has lost -2.77%. Vanda Pharmaceuticals Inc shares have risen nearly 16.35% since the year began. Nevertheless, the stocks have risen 25.90% over the past one year. While a 52-week high of $6.75 was reached on 06/13/24, a 52-week low of $3.46 was recorded on 02/06/24. SMA at 50 days reached $4.83, while 200 days put it at $5.00.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 4.84, which if violated will result in even more drops to 4.77. On the upside, there is a resistance level at 5.01. A further resistance level may holdings at 5.11. The Relative Strength Index (RSI) on the 14-day chart is 47.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.23%. Stochastics %K at 29.54% indicates the stock is a holding.
How much short interest is there in Vanda Pharmaceuticals Inc?
A steep rise in short interest was recorded in Vanda Pharmaceuticals Inc stocks on 2024-11-15, dropping by -0.76 million shares to a total of 3.22 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 3.98 million shares. There was a decline of -23.5%, which implies that there is a negative sentiment for the stock.
